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that MHC class II molecules possess two independent
binding sites for bacterial SAGs: a low-affinity site (KD 5
z1025 M) on the conserved a chain and a zinc-depen-Summary
dent, high-affinity site (KD 5 z1027 M) on the polymor-
phic b chain (Papageorgiou and Acharya, 1997; Li et al.,MHC class II molecules possess two binding sites for
1999). Certain SAGs bind exclusively to the low-affinitybacterial superantigens (SAGs): a low-affinity site on
site (SEB, TSST-1), while others bind to both the low-the a chain and a high-affinity, zinc-dependent site on
and high-affinity sites (SEA) or only to the high-affinitythe b chain. Only the former has been defined crystal-
one (SPE-C) (Abrahmsen et al., 1995; Hudson et al.,lographically. We report the structure of streptococcal
1995; Kozono et al., 1995; Li et al., 1997; Roussel et al.,pyrogenic exotoxin C (SPE-C) complexed with HLA-
1997). To date, however, only the low-affinity site hasDR2a (DRA*0101, DRB5*0101) bearing a self-peptide
been defined by X-ray crystallography. In the complexfrom myelin basic protein (MBP). SPE-C binds the b
between SEB and HLA-DR1, the SAG binds the a1 do-
chain through a zinc bridge that links the SAG and
main of DR1, contacting residues from the first and third
class II molecules. Surprisingly, SPE-C also makes turns of the b sheet and from the N-terminal portion of
extensive contacts with the MBP peptide, such that the a helix (Jardetzky et al., 1994). The binding of SEB
peptide accounts for one third of the surface area of to HLA-DR4 is similar (Dessen et al., 1997). SEB binds
the MHC molecule buried in the complex, similar to outside of the peptide binding groove of the class II
TCR-peptide/MHC complexes. Thus, SPE-C may opti- molecule and does not contact the bound peptide. Al-
mize T cell responses by mimicking the peptide depen- though the TSST-1 binding site on HLA-DR1 overlaps
dence of conventional antigen presentation and rec- that of SEB, the two SAGs bind differently (Kim et al.,
ognition. 1994). Whereas SEB binds primarily off one edge of the
peptide binding groove, TSST-1 extends over nearly half
Introduction the groove and contacts the a helix of the a1 domain
of DR1, part of the a helix of the b1 domain, and, proba-
Superantigens (SAGs) are a class of immunostimulatory bly, the bound peptide. A precise definition of peptide-
and disease-causing proteins of bacterial or viral origin SAG contacts in the TSST-1/HLA-DR1 complex was
precluded, however, because the class II protein waswith the ability to activate up to 20% of all T cells,
purified directly from lymphoblastoid cells and thereforecompared to only one in 105 to 106 T cells during normal
contained a heterogeneous mixture of naturally pro-antigen presentation. SAGs activate T cells by simulta-
cessed peptides (Kim et al., 1994).neously binding T cell receptors (TCRs) and MHC class II
In order to define the high-affinity, zinc-dependentmolecules, resulting in the massive release of pyrogenic
site for SAGs on MHC class II, we have determinedand inflammatory cytokines such as IL-1, IL-2, TNFa,
the crystal structure, to 3.2 A˚ resolution, of SPE-C inand TNFb (Kotzin et al., 1993; Scherer et al., 1993; Li et al.,
complex with HLA-DR2a (DRA*0101, DRB5*0101) loaded1999). The best-characterized group of SAGs belongs to
with an immunodominant self-peptide from myelin basicthe pyrogenic toxin SAG family, which includes the
protein (MBP). SPE-C is highly associated with strepto-staphylococcal enterotoxins A through M (SEA to SEM,
coccal toxic shock syndrome and other invasive strepto-
coccal diseases (Cone et al., 1987; Cleary et al., 1992;k To whom correspondence should be addressed (e-mail: mariuzza@
Cockerill et al., 1998), while HLA-DR2a correlates withcarb.nist.gov).
increased susceptibility to multiple sclerosis (Hillert et# Present address: Wadsworth Center, New York State Department
al., 1994; Ebers et al., 1996; Oksenberg et al., 1996). Theof Health, P.O. Box 509, Empire State Plaza, Albany, New York
12201. structure of the HLA-DR2a/MBP/SPE-C complex shows
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Table 1. Crystal Data and Structure Refinement Statistics
Data Collection
Space group I222
Unit cell (A˚) a 5 61.8, b 5 112.0, c 5 216.6
Number of molecules/asymmetric unit 1 HLA-DR2a/MBP/SPE-C complex
Resolution (A˚) 3.2
Observations 141,485
Unique reflections 11,585
Completeness (%) 90.2 (92.7)a
Mean I/s(I) 12.4 (5.1)a
Rsym (%)b 11.0 (36.2)a
Refinement
Resolution range (A˚) 100–3.2
Rwork (%)b 22.4
Rfree (%)b 28.8
Nonhydrogen protein atoms 4602
Average B factors (A˚2)
Overall 39.7c/42.8d
HLA-DR2a 42.3c/44.3d
a1, b1 domains 31.4c/38.8d
a2, b2 domains 52.0c/50.0d
MBP 36.2c/51.6d
SPE-C 41.5c/43.1d
Zn 27.0
Rms deviations from ideality
Bonds (A˚) 0.008
Angles (8) 1.4
a Values in parentheses correspond to the highest resolution shell (3.3–3.2 A˚).
b Rsym 5 ou(Ihkl 2 Ikhkll)u/(oIhkl), where Ikhkll is the mean intensity of all reflections equivalent to reflection hkl by symmetry; Rwork (Rfree) 5 ouu Fo u 2
u Fc u /ou Fo uu, where Fc is the calculated structure factor; 9% of data were used for Rfree.
c Values for main chains.
d Values for side chains.
that SPE-C binds to the high-affinity site on the class II b ties (KD 5 z4 3 1028 M; data not shown), only SPE-C
H35A crystallized with HLA-DR2a/MBP 89-101. Thechain through a zinc bridge, consistent with mutagenesis
crystals contain one molecular complex molecule perand biochemical studies of SEA and SPE-C (Herman et
asymmetric unit. The structure of the complex wasal., 1991; Abrahmsen et al., 1995; Hudson et al., 1995;
solved by the molecular replacement method, usingLi et al., 1997). This mode of MHC engagement is distinct
HLA-DR2a/MBP 86-105 (Li et al., 2000) and wild-typefrom those employed by the low-affinity SAGs SEB (Jar-
SPE-C (Roussel et al., 1997) as search models. Crystallo-detzky et al., 1994) and TSST-1 (Kim et al., 1994). The
graphic data collection and refinement statistics arestructure also reveals that SPE-C makes extensive con-
summarized in Table 1. The peptide binding a1 and b1tacts with the bound MBP peptide, strongly suggesting
domains of HLA-DR2a and the entire SPE-C moleculethat the interaction between this SAG and MHC class
are more ordered than the a2 and b2 domains, as re-II, like that between TCR and MHC, is at least partially
flected by lower mean temperature (B) factors (Table 1).peptide dependent. This feature may have evolved to
Residue 130 of the a2 domain and loops 105–111 andpromote high-affinity but low-density binding to MHC on
167–168 of the b2 domain lack electron density. By con-the surface of antigen-presenting cells (APCs), thereby
trast, all residues in the interface between HLA-DR2a/avoiding T cell apoptosis induced by high ligand density
MBP 89-101 and SPE-C are well defined. In particular,(Lenardo, 1991; Critchfield et al., 1994; Alexander-Miller
both the main chain and side chains of the bound MBPet al., 1996; Lenardo et al., 1999). By mimicking conven-
peptide (VHFFKNIVTPRTP) display unambiguous elec-tional antigen presentation and recognition in this way,
tron density, except for the two C-terminal residues,SAGs such as SPE-C are able to stimulate T cells with
which are not part of the interface with the SAG.an efficiency comparable to that achieved by specific
The overall structure of the HLA-DR2a/MBP/SPE-Cpeptide/MHC ligands.
H35A complex is shown in Figure 1A. In the complex,
the b grasp motif of the C-terminal domain of SPE-C
Results and Discussion contacts the a helix of the b1 domain of HLA-DR2a as
well as the N-terminal portion of the MBP peptide. There
Overview of the Complex Structure are no direct contacts between the a1 domain of HLA-
We determined the structure, to 3.2 A˚ resolution, of the DR2a and SPE-C. The interaction between HLA-DR2a
complex between HLA-DR2a/MBP 89-101 and a mutant and SPE-C is mediated, in part, by a zinc ion, which
of SPE-C in which histidine at position 35 is replaced corresponds to one of the two bound zincs in the struc-
by alanine (SPE-C H35A). Although the mutant and wild- ture of the unliganded SAG (Roussel et al., 1997). This
mode of MHC engagement is completely distinct fromtype SAGs bound the class II molecule with similar affini-
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Figure 1. HLA-DR2a/SPE-C Complex and Comparison with HLA-DR1/SEB and HLA-DR1/TSST-1 Complexes
(A) Ribbons diagram of the HLA-DR2a/SPE-C complex. Colors are as follows: DR2a a chain, green; DR2a b chain, light blue; SPE-C, gray;
and peptide, pink. The interface zinc ion is drawn as a yellow sphere.
(B) Ribbons diagram of the HLA-DR1/SEB complex (Jardetzky et al., 1994). DR1 a chain, green; DR1 b chain, light blue; SEB, dark blue; and
peptide, pink.
(C) Ribbons diagram of the HLA-DR1/TSST-1 complex (Kim et al., 1994). DR1 a chain, green; DR1 b chain, light blue; TSST-1, yellow; and
peptide, pink.
those employed by SEB (Jardetzky et al., 1994; Figure volume values but assuming the presence of a very
weak reversible monomer–dimer equilibrium. Best-fit1B) and TSST-1 (Kim et al., 1994; Figure 1C), which both
bind the a1 domain, without the participation of metal equilibrium dissociation constants obtained from this
model are 390 (6 90) mM for wild-type SPE-C and 680 (6ions.
As shown in Figure 1A, the SPE-C H35A mutant binds 200) mM for SPE-C H35A. However, given that SPE-C
is biologically active at picomolar concentrations (Li etthe MHC class II molecule as a monomer. In contrast,
unliganded wild-type SPE-C crystallizes as a homodi- al., 1997), we conclude that both wild-type SPE-C and
SPE-C H35A engage MHC class II as monomers undermer (Roussel et al., 1997) and also appears to dimerize
in solution, as judged by size exclusion chromatography physiological conditions.
(Li et al., 1997). Because the histidine to alanine substitu-
tion at position 35 is located in the putative dimer inter- Structure of the Interface: Role of Zinc and the Bound
Peptide in Complex Stabilizationface in the wild-type SPE-C structure (but distant from
the interface with class II), we tested whether the muta- The interaction between HLA-DR2a/MBP and SPE-C
buries 1625 A˚2 of surface area, of which 837 A˚2 is contrib-tion could have disrupted dimerization. In our hands,
both the mutant and wild-type SAGs eluted as mono- uted by the SAG and 788 A˚2 by peptide/MHC. The total
buried surface is within the range observed for protein–mers from a Superdex 75 column at neutral pH, with little
or no indication of dimer formation (data not shown). To protein recognition sites (Lo Conte et al., 1999) and is
comparable to the z1800 A˚2 of buried surface in TCR-confirm this result, we measured the molar masses of
wild-type SPE-C and SPE-C H35A by sedimentation peptide/MHC class I and class II complexes (Garcia et al.,
1999; Reinherz et al., 1999). Unexpectedly, 35% (273 A˚2)equilibrium. The concentration profiles in sedimentation
equilibrium could be modeled over the entire range of of the solvent-accessible surface of HLA-DR2a/MBP 89-
101 buried in the complex with SPE-C is contributed byrotor speeds and measured concentrations (0.05–80 mM
for SPE-C and 0.05–35 mM for SPE-C H35A) as a mono- the MBP peptide. For TCR-peptide/MHC complexes, by
comparison, about 30% of the buried MHC class I ormeric single species with molar masses of 26,330 (6 250)
Da and 25,080 (6 250) Da for the wild-type and mutant class II surface involves the antigenic peptide (Garcia
et al., 1999; Reinherz et al., 1999). This strongly impliesSAG, respectively (Figure 2). That the molar mass values
are slightly higher than those predicted from the amino that the MBP peptide plays an important role in binding
the SAG, although confirmation must await affinity mea-acid sequences (24,293 and 24,227 Da for SPE-C and
SPE-C H35A, respectively) could be the result of small surements using peptide analogs. Application of the
algorithm of Lawrence and Coleman (1993) for quantitat-(2%–3%) errors in the prediction of the partial specific
volumes from amino acid compositions, which are am- ing shape complementarity in protein–protein interfaces
to the HLA-DR2a/MBP/SPE-C complex gives a shapeplified by the buoyancy term of ultracentrifugal mass
determination (Laue et al., 1992; Schuck and Braswell, correlation statistic (Sc) of 0.65 (Sc 5 1 for interfaces with
perfect fits), which is within the range for TCR-peptide/2000). Alternatively, the data can be modeled using the
theoretically predicted molar mass and partial specific MHC complexes (Sc 5 0.46–0.70). The affinity of SPE-C
Immunity
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Figure 2. Determination of Solution Molecu-
lar Masses of Wild-Type SPE-C and SPE-C
H35A by Sedimentation Equilibrium
The data are modeled as a monomeric single
species. Multiple equilibrium absorbance dis-
tributions obtained at several loading con-
centrations (c0) and rotor speeds (v) were
globally analyzed, resulting in rms deviations
smaller than 0.007 OD.
(Top) Wild-type SPE-C at c0 5 25 mM, 30,000
rpm, scanned at 250 nm (triangles) and at
c0 5 1.8 mM, 25,000 rpm, scanned at 230 nm
(plus symbols). Also shown are SPE-C H35A
mutant data (offset by 0.25 OD) with c0 5 12.6
mM at 30,000 rpm, scanned at 280 nm (circles)
and c0 5 2.3 mM at 25,000 rpm, scanned at
230 nm (x). Solid lines are best-fit single spe-
cies models with molar masses of 26,330 Da
(wild-type) and 25,080 Da (H35A).
(Bottom) Residuals of the fits.
for HLA-DR2a/MBP (0.04 mM) is much closer to that of of uncomplexed SPE-C (Roussel et al., 1997), the fourth
zinc ligand is a histidine provided by a symmetry-relatedTCR D10 for I-Ak/CA (1 mM) than of TCR 2C for H-2Kb/
dEV8 (100 mM), consistent with the Sc values of the TCR SAG molecule. The presence of zinc in the interface
between SPE-C and HLA-DR2a and its importance inD10/I-Ak/CA and TCR 2C/H-2Kb/dEV8 complexes (0.70
and 0.46, respectively) (Garcia et al., 1999; Reinherz et complex formation is supported by the finding that EDTA
completely abolishes the binding of SPE-C to humanal., 1999).
The site on HLA-DR2a/MBP recognized by SPE-C is cells expressing MHC class II (Li et al., 1997). In addition,
a mutant of SPE-C in which Asp-203 is replaced bycomprised of (1) the N-terminal portion of the a helix of
the DR2a b1 domain, which lies across the parallel b alanine is nonlethal in a rabbit model of toxic shock
syndrome (P. S. Schlievert, personal communication).strands (b6 and b12) of the C-terminal domain of SPE-C
and contacts strands b6, b7a, b12, and the turn between The identification of MHC class II residue His-81b as
the fourth zinc ligand in the HLA-DR2a/MBP/SPE-Cb9 and b10 (Figure 3A); (2) the turn between the b1 and
b2 strands of the DR2a b1 domain, which contacts the complex agrees with site-directed mutagenesis and bio-
chemical studies implicating His-81b of HLA-DR1 in aturn between the b9 and b10 strands of SPE-C (Figure
3A); and (3) the N-terminal half of the MBP peptide, zinc bridge to SEA (Herman et al., 1991; Hudson et al.,
1995).which contacts strands b6, b7a, b9, and b12 of the SAG
(Figures 3B and 3C). As shown in Figure 3C, SPE-C contacts the N-terminal
portion of the MBP peptide from P-3 to P3 (Table 2),The interaction of the MHC b1 helix with SPE-C is
dominated by residues Asp-76b, Thr-77b, and His-81b, where P1 Phe is the first anchor residue (Li et al., 2000).
TCRs, by contrast, bind antigenic peptides more cen-which form three hydrogen bonds and numerous van
der Waals contacts with the SAG (Table 2) and that trally, at and around the P5 position (Garcia et al., 1999;
Reinherz et al., 1999) (compare Figures 4A and 4B). Intogether contribute 208 A˚2 to the buried surface of HLA-
DR2a/MBP (26% of the total). By contrast, the interac- this regard, it should be noted that, based on superposi-
tions of known MHC class II/peptide crystal structurestion of the first turn of HLA-DR2a b sheet with SPE-C
is restricted to Thr-21b, which makes a single hydrogen (Stern et al., 1994; Ghosh et al., 1995; Dessen et al.,
1997; Murthy and Stern, 1997; Smith et al., 1998; Li etbond to Asp-164 of the SAG. A zinc ion is observed to
bridge HLA-DR2a and SPE-C by tetrahedrally coordinat- al., 2000), the N-terminal segments (to residue P4) of
peptides bound to class II molecules display less confor-ing three ligands from the SAG (His-167 from strand b10
and His-201 and Asp-203 from strand b12) with one mational divergence than their C-terminal segments
(from residue P5). This suggests that SPE-C binds aligand from the MHC b1 helix (His-81b) (Figure 3A). Histi-
dines 167 and 201 of SPE-C bind through their Ne2 more structurally conserved region of the antigenic rec-
ognition surface of MHC/peptide complexes than doatoms, while His-81b of HLA-DR2a binds through its
Nd1 atom (Figure 3D). All the metal ligand distances TCRs. Three peptide residues, P-1 Phe, P2 Lys, and P3
Asn, account for the majority of interactions with the(1.9–2.2 A˚) and coordination angles (978–1168) are within
the ranges seen for tetrahedrally coordinated zinc ions SAG and are almost completely buried in the interface.
Of these, P-1 Phe buries the most surface (73 A˚2), pack-in proteins (Alberts et al., 1998). In the crystal structure
Structure of Superantigen/MHC Class II Complex
97
Figure 3. Interactions in the HLA-DR2a/MBP/SPE-C Interface
(A) Interactions between the HLA-DR2a b chain (blue) and SPE-C (gray). Residues of HLA-DR2a and SPE-C involved in interactions are brown
and green, respectively. The interface zinc ion is drawn as a yellow sphere. Hydrogen bonds are represented as broken black lines.
(B) Electron density for the MBP peptide. The j2Fo-Fcu annealed omit map at 3.2 A˚ resolution is contoured at 1s. The entire MBP peptide was
omitted for generation of the map.
(C) Interactions between the MBP peptide (pink) and SPE-C (gray). Peptide residues P-2, P-1, P2, and P3 contact the SAG. Residues of SPE-C
in contact with the peptide are green.
(D) Coordination geometry of the interface zinc ion. The zinc is tetrahedrally coordinated by SPE-C residues His-167, His-201, and Asp-203
(green) and HLA-DR2a residue His-81b (brown). Oxygen and nitrogen atoms are colored red and blue, respectively.
ing against SPE-C Phe-107 and Tyr-205 to form a tight as ones that are unique to MBP. Since naturally pro-
cessed foreign and self-peptides eluted from purifiedhydrophobic cluster (Figure 3B). SPE-C Gln-113 also
appears important in peptide recognition, forming two of HLA-DR2a molecules exhibit considerable sequence di-
versity at SPE-C-contacting positions P-2, P-1, P2, andthree hydrogen bonds to MBP (Table 2) and contributing
121 A˚2 of buried surface. P3 (Vogt et al., 1994), a wide range of affinities for SPE-C
binding to MHC/peptide complexes on APCs might beOverall, the MBP peptide contributes 38% of the van
der Waals contacts to SPE-C, compared to 62% by expected.
While there is currently no information on the degreethe HLA-DR2a b1 helix. In addition, the bound peptide
mediates three of eight hydrogen bonds linking HLA- to which the binding of SPE-C to HLA-DR2a/MBP is
dependent on the sequence of the associated peptide,DR2a/MBP to the SAG (Table 2). Approximately one half
(54%) of the contacts of MBP to SPE-C are through side several studies have provided evidence that the presen-
tation of some bacterial SAGs by MHC class II is stronglychain atoms of the peptide and one half (46%) through
backbone atoms. Similarly, hydrogen bonds formed be- affected by class II–bound peptides. Thus, TSST-1 and
SEB do not compete with each other for binding to HLA-tween MBP and SPE-C involve both peptide side chain
and main chain atoms (Table 2). Therefore, the SAG very DR1 molecules on APCs (Scholl et al., 1990; Chintagum-
pala et al., 1991; Thibodeau et al., 1994), even thoughlikely recognizes certain features of bound MBP that are
conserved in other class II–associated peptides, as well crystallographic studies demonstrate that these SAGs
Immunity
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Table 2. Interactions between HLA-DR2a/MBP and SPE-C in the HLA-DR2a/MBP/SPE-C Complex
SPE-C
HLA-DR2a/MBP Hydrogen Bondsa Van der Walls Contactsb
Thr-21 b Og1 Asp-164 O Lys-163, Asp-164, Gly-165
Asp-70 b Asn-115, Asn-117
Ala-73 b Leu-103, Asn-117
Asp-76 b Od1 Ser-200 Og Leu-103, Ser-200, His-201
Thr-77 b O Asn-105 Nd2 Leu-103, Gly-104, Asn-105, Asn-117, His-201
Arg-80 b Ne Lys-163 O Lys-163
His-81 b Nd1 Asp-203 Od1 Asn-105, Phe-107, His-167, His-201, Asp-203
Gly-84 Gly-165
Val-P-3 Arg-157, Tyr-205
His-P-2 Nd Glu-159 Oe 1 Arg-157
Phe-P-1 Phe-107, Tyr-205
Phe-P1 Gln-113
Lys-P2 Asn-105, Phe-107, Gln-113
Asn-P3 N Gln-113 Oe 1 Gln-113
O Ne
a Hydrogen bonds were calculated using a 2.5–3.4 A˚ donor–acceptor distance.
b Van der Waals contacts ,4.0 A˚.
bind to overlapping regions on the HLA-DR1 a chain that would result if the SAGs were able to bind equally
well to all class II molecules on the APC surface. Indeed,(Jardetzky et al., 1994; Kim et al., 1994). These data imply
that TSST-1 and SEB interact with different subsets of the capacity of high ligand densities to induce T cell
apoptosis is well documented both for peptide/MHCDR1 molecules, perhaps distinguished by the repertoire
of peptides bound to them (Thibodeau et al., 1994). and SAGs (Suzuki et al., 1988; Lenardo, 1991; Critchfield
et al., 1994; Alexander-Miller et al., 1996; Renno et al.,Indeed, certain peptides were found to promote the
presentation of TSST-1 to T cells by I-Ab up to 5000- 1996; Lenardo et al., 1999). Restriction of the presenta-
tion density of SPE-C through peptide-dependent bind-fold (Wen et al., 1996, 1997). Similarly, using soluble
I-E class II molecules engineered to contain a single ing to MHC class II would ensure appropriate activation
at the level of the individual T cell, while the high fre-covalently attached peptide, Kozono et al. (1995)
showed that the N-terminal sequence of the peptide quency of responding T cells, which is determined by the
Vb specificity of the SAG, dictates the overall strength ofstrongly affects the kinetics of the interaction between
SEA and MHC class II. This result may be explained by the response.
the structure of the HLA-DR2a/MBP/SPE-C complex,
since, as discussed below, SEA and SPE-C very likely Conformational Changes in the Interface
The availability of high-resolution crystal structures forbind the class II b chain similarly, contacting N-terminal
residues of the bound peptide. uncomplexed HLA-DR2a/MBP (Li et al., 2000) and
SPE-C (Roussel et al., 1997) allows us to assess whetherAlthough the peptide dependence of SEA, TSST-1,
and (probably) SPE-C appears inconsistent with the idea any conformational changes occur in the MHC class II/
peptide or SAG upon complex formation. The free andthat SAGs have evolved to maximize TCR/MHC interac-
tions, several considerations suggest that peptide de- complexed HLA-DR2a/MBP molecules superpose with
a root-mean-square (rms) difference of 0.78 A˚ for all apendence could play a crucial role in modulating SAG
activity (Wen et al., 1996; Woodland et al., 1997). For carbon atoms; for the a1/b1 domains alone, the rms
difference is 0.49 A˚. Similarly, the unbound and boundexample, MHC class II–associated peptides may allow
SAGs to distinguish between different types of APCs, SPE-C molecules superpose with an rms difference of
0.62 A˚. Thus, there are no major rearrangements in thesuch that SAGs are preferentially targeted to dendritic
cells or macrophages and away from cells expressing polypeptide backbones of HLA-DR2a or SPE-C associ-
ated with complex formation, as was also noted for themore restricted peptide repertoires. This possibility is
supported by studies showing that different cell types HLA-DR1/SEB (Jardetzky et al., 1994) and HLA-DR1/
TSST-1 complexes (Kim et al., 1994). However, a numberexpressing identical MHC class II alleles differ in their
ability to present bacterial SAGs to T cells (Bhardwaj et of small adjustments in DR2a/MBP and SPE-C side
chain positions are evident in comparing the free andal., 1993; Thibodeau et al., 1994; Yagi et al., 1994; Lavoie
et al., 1997). A more likely possibility, however, is that the bound structures. Certain of these changes are neces-
sary to avoid steric clashes between MHC/peptide andability of certain SAGs to discriminate between different
MHC class II/peptide complexes actually enhances their SAG, while others probably serve to maximize produc-
tive interactions between the two proteins. Indeed, thepotency (Wen et al., 1996; Woodland et al., 1997). In
this case, the peptide dependence of SAGs like SEA, Sc value of an artificial complex, constructed by super-
posing the a1/b1 domains of free HLA-DR2a/MBP andTSST-1, and SPE-C serves as a mechanism for promot-
ing high-affinity but low-density binding of these SAGs free SPE-C onto the corresponding elements of the
DR2a/MBP/SPE-C crystal structure, is 0.52, comparedto MHC class II. By mimicking the low antigen densities
normally encountered by T cells on APCs, SAGs such to 0.65 for the actual complex.
Among the observed conformational changes, a rota-as SPE-C may avoid inappropriate or suboptimal T cell
signaling as a consequence of the very high densities tion of the imidazole ring of HLA-DR2a His-81b displaces
Structure of Superantigen/MHC Class II Complex
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Figure 4. Comparison of the Docking Modes of SAGs and TCR on MHC Class II
(A) View of the HLA-DR2a/MBP/SPE-C complex looking down into the peptide binding groove of the class II molecule. The N terminus of the
MBP peptide (pink) is at the upper left. Colors are as follows: DR2a a1 domain, green; DR2a b1 domain, light blue; and SPE-C, gray.
(B) The complex between TCR D10 (purple) and I-Ak bearing a conalbumin peptide (Reinherz et al., 1999). The orientation of the class II
molecule is the same as in (A).
(C) The complex between SEB (dark blue) and HLA-DR1 (Jardetzky et al., 1994).
(D) The complex between TSST-1 (yellow) and HLA-DR1 (Kim et al., 1994).
Nd1 by 1.3 A˚, enabling it to coordinate zinc and hydrogen those observed in other protein/protein complexes and
underscore the importance of structural flexibility inbond with Od1 of SPE-C Asp-203. In the MBP peptide,
the Ca of P-3 Val is pushed 1.7 A˚ from SPE-C, and its macromolecular recognition (Sundberg and Mariuzza,
2000).Cb is displaced by 2.1 A˚. The imidazole ring of P-2 His
shifts 3.7 A˚ away from the SAG. The phenyl ring of P-1
Phe rotates 308 to optimize hydrophobic interactions Comparison with Other MHC Class II–SAG Complexes
The structure of the HLA-DR2a/SPE-C complex de-with SPE-C Phe-107, while the side chain of P2 Lys
moves as far as 6.5 A˚ to avoid steric clashes with this scribed here differs markedly from those of the HLA-
DR1/SEB (Jardetzky et al., 1994) and HLA-DR1/TSST-1same SPE-C residue. Structural rearrangements of simi-
lar magnitude occur in SPE-C. These changes in the (Kim et al., 1994) complexes (Figure 1). In the latter two
complexes, residues of SEB and TSST-1 in contact withconformation of interface residues are comparable to
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MHC class II derive from the N-terminal rather than Furthermore, the orientation of the class II molecules in
C-terminal domain of the SAG. Unlike SPE-C, which our MHC2SEA model is compatible with SEA-mediated
binds to the class II b1 domain, SEB and TSST-1 bind cross-linking of class II on the APC surface—a require-
to the a1 domain. Whereas SPE-C makes extensive con- ment for T cell activation by this SAG (Mehindate et al.,
tacts with the bound peptide, SEB binds away from 1995; Teidemann and Fraser, 1996). As shown in Figure
the peptide binding groove of HLA-DR1 and does not 5B, the polypeptide termini connecting the two MHC to
interact with peptide (Figure 4C). In contrast, TSST-1 the cell surface are pointing in the same direction, such
extends over nearly half the binding groove and proba- that the cross-linked molecules could lie in the plane of
bly contacts the bound peptide. However, the contacts the membrane.
are to the C-terminal rather than N-terminal portion of
the peptide (Figure 4D). Interaction of SPE-C with Other MHC
Although no crystal structures have been reported for Class II Molecules
SEA complexed with MHC class II molecules, mutagene- Li et al. (1997) showed that SPE-C binds with high affin-
sis and binding studies have demonstrated that SEA ity, in a zinc-dependent fashion, to both human HLA-
possesses two binding sites for class II: (1) a low-affinity DR and mouse I-E molecules but not to mouse I-A.
site to the class II a chain analogous to the DR1 binding Sequence comparison of HLA-DR, I-E, and I-A b chains
site of SEB and (2) a high-affinity, zinc-dependent site does not provide an obvious explanation for this differ-
to the class II b chain (Abrahmsen et al., 1995; Hudson ence, since most of the residues of HLA-DR2a con-
et al., 1995; Kozono et al., 1995). Examination of the tacting SPE-C in the HLA-DR2a/MBP/SPE-C complex
three-dimensional structures of SEA (Schad et al., 1995), are conserved in I-E and I-A. Although there are no
SPE-C (Roussel et al., 1997), and the HLA-DR2a/SPE-C structures of SPE-C bound to other class II molecules,
complex reveals that the high-affinity class II binding the known structures of free I-Ek (Fremont et al., 1996),
site of SEA corresponds to that of SPE-C. Structurally I-Ad (Scott et al., 1998), and I-Ak (Fremont et al., 1998)
homologous regions of the two SAGs (strands b6, b9, allow us to superpose their a1/b1 domains onto those
and b12), containing the principal contact residues to of HLA-DR2a. This comparison reveals that the main
class II in the HLA-DR2a/SPE-C complex, are shown chain of I-A residue Glu-84b would make sterically unfa-
superposed in Figure 5A. Strands b6 of SPE-C, from vorable contacts as close as 1.8 A˚ with SPE-C Gly-165,
Leu-103 to Phe-107, and b12, from His-201 to Tyr-205, assuming that I-A binds SPE-C the same way as HLA-
coincide with the corresponding strands of SEA, from DR2a. This difference between I-A and HLA-DR2a or I-E
Pro-126 to Try-130 and His-225 to Tyr-229, respectively. is due to an insertion between residues b84 and b85.
The side chain conformations of MHC/peptide-con- Another difference that could affect the interaction of
tacting residues Asn-105, Gln-113, His-201, Asp-203, SPE-C with I-A is the position of the bound peptide;
and Tyr-205 of SPE-C are very close to those of the residues P3 to P6 sit lower in the I-A groove than in
equivalent residues of SEA (Asn-128, Gln-135, His-225, the DR or I-E groove, potentially disrupting productive
Asp-227, and Tyr-205, respectively). Even residues of contacts between the P3 backbone and the SPE-C Gln-
SPE-C (Leu-103 and Phe-107) that differ in SEA (Pro- 113 side chain (Table 2; Figure 2C).
126 and Trp-130) display similar side chain orientations,
such that certain of the interactions with MHC/peptide
Conclusions
mediated by these SPE-C residues could also be made
by the corresponding SEA residues. The zinc site of
The structure of the complex between SPE-C and HLA-SPE-C corresponds in both position and geometry to
DR2a/MBP illustrates the different strategies bacterialthe zinc site of SEA. In SEA, however, one of the zinc
SAGs employ for engaging MHC class II molecules. Un-ligands, His-187, is situated on strand b9, whereas the
like SEB and TSST-1, which bind to a low-affinity siteequivalent ligand in SPE-C, His-167, is on strand b10,
on the class II a chain through their N-terminal domains,as previously noted (Roussel et al., 1997).
SPE-C binds to a high-affinity site on the b chain throughIt has been proposed that SEA cross-links MHC class
its C-terminal domain. In addition, the interaction be-II molecules on the surface of APCs through its low-
tween SPE-C and HLA-DR2a is mediated by a bridgingaffinity and high-affinity MHC binding sites, thereby en-
zinc ion, which tetrahedrally coordinates three ligandshancing T cell stimulation (Mehindate et al., 1995; Tiede-
from the SAG with one from the MHC b1 helix (His-81b).mann and Fraser, 1996). Since the low-affinity MHC
A provocative feature of the HLA-DR2a/MBP/SPE-Cbinding site of SEA is analogous to that of SEB (Schad
complex is the extensive interaction of the class II–et al., 1995) and the high-affinity site to that of SPE-C,
associated peptide with the SAG, suggesting that pep-a model of the putative MHC2SEA complex may be con-
tide can directly influence SPE-C binding and presenta-structed by least-squares superposition of (1) the HLA-
tion. Indeed, the peptide accounts for one third of theDR2a/SPE-C complex, (2) SEA (Schad et al., 1995), and
surface area of the MHC class II molecule buried in(3) the HLA-DR1/SEB complex (Jardetzky et al., 1994)
the complex, which is similar to the contribution of the(Figure 5B). The accuracy of this model depends, in part,
antigenic peptide in TCR-peptide/MHC complexes (Gar-on the assumption that there are no major conforma-
cia et al., 1999; Reinherz et al., 1999). This finding istional changes in any of the individual components upon
consistent with evidence that the presentation of somecomplex formation; such changes are unlikely, given
bacterial SAGs, in particular SEA and TSST-1, by MHCthat none are observed in the HLA-DR1/SEB and HLA-
class II is strongly affected by class II–bound peptidesDR2a/SPE-C complexes. In the hypothetical MHC2SEA
(Kozono et al., 1995; Wen et al., 1996; Woodland etcomplex, there is no overlap between class II molecules
al., 1997). Whereas SAGs like SEB and SEC circumventbound to the high-affinity and low-affinity sites of SEA,
indicating that one SEA can interact with two MHC. normal MHC restriction by binding to class II away from
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Figure 5. High-Affinity Binding Site of SEA and Model of MHC Cross-Linking
(A) Comparison of the high-affinity binding sites of SPE-C and SEA for MHC class II. The region of unbound SPE-C (gray) (Roussel et al.,
1997) containing the principal contact residues to class II in the HLA-DR2a/MBP/SPE-C complex was superposed onto the corresponding
region of unbound SEA (orange) (Schad et al., 1995). Side chains of SPE-C that interact with MHC class II/peptide are green; the corresponding
side chains of SEA are red.
(B) Model of SEA cross-linking two MHC class II molecules. SEA is orange, and the a and b chains of HLA-DR2a are green and light blue,
respectively. The peptides are pink, and the interface zinc is a yellow sphere. The model was constructed by least-squares superposition of
(1) the HLA-DR2a/SPE-C complex, (2) SEA (Schad et al., 1995), and (3) the HLA-DR1/SEB complex (Jardetzky et al., 1994). The C termini of
the class II a and b chains are labeled.
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suite, using a probe radius of 1.4 A˚. The refinement statistics arethe peptide binding groove, others like SPE-C, SEA, and
summarized in Table 1. Atomic coordinates have been depositedTSST-1 appear to mimic the peptide dependence of
in the Protein Data Bank as entry 1HQR.conventional antigen presentation in order to limit pre-
sentation density and avoid the induction of T cell apo- Sedimentation Equilibrium
ptosis. Thus, bacterial SAGs have evolved diverse Sedimentation equilibrium studies were conducted using a Beck-
means of achieving the same end result—highly efficient man Optima XL-A analytical ultracentrifuge equipped with ab-
sorbance optics. Wild-type SPE-C and SPE-C H35A mutant wereT cell activation comparable to that by specific peptide/
brought into PBS via gel filtration, and double-sector charcoal-filledMHC complexes.
epon centerpieces were filled with 180 ml of sample at concentra-
tions between 1.8 and 25 mM. Sedimentation equilibrium was at-
Experimental Procedures
tained at a rotor temperature of 48C and at rotor speeds of 20,000,
25,000, and 30,000 rpm. Absorbance profiles were acquired at wave-
Protein Expression, Purification, and Crystallization
lengths of 230, 250, and 280 nm, dependent on SPE-C concentra-
The HLA-DR2a/MBP 89-101 complex was folded in vitro from bacte-
tion. The extinction coefficient at 280 nm and the partial specific
rial inclusion bodies and purified as described (Frayser et al., 1999;
volume of 0.723 ml/g at 48C were calculated from amino acid compo-
Li et al., 2000), except that the MBP peptide (VHFFKNIVTPRTP) used
sition, and the buffer density of 1.00702 g/ml was calculated with
here is seven residues shorter than the MBP 86-105 peptide. Both
compositional density increments and temperature coefficients ac-
wild-type SPE-C and the H35A mutant were expressed in Esche-
cording to Laue et al. (1992). Data analysis was performed by global
richia coli BL21(DE3) as described (McCormick et al., 2000). The
analysis of several data sets obtained at different loading concentra-
SAGs were purified by successive preparative flatbed isoelectric
tions and rotor speeds. No thermodynamic nonidealities were ob-
focusing, using pH gradients of 3.5–10 and 6–8. Further purification
served, and least-squares fits were based on superpositions of the
was carried out by size exclusion chromatography on a Superdex
Boltzmann distributions of ideal species in the centrifugal field
75 FPLC column (Pharmacia) equilibrated in HBS. Both the wild-
(Svedberg and Pedersen, 1940). For the reversible monomer–dimer
type and mutant toxins eluted as monomers.
model, the exponentials for the monomer and dimer were linked by
Crystallization trials were carried out by mixing HLA-DR2a/MBP
mass action law.
89-101 with SPE-C or SPE-C H35A at different molar ratios; only
the mutant SAG yielded crystals. The HLA-DR2a/MBP/SPE-C H35A
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